NASDAQ
03.12.24
16:35 Uhr
8,630 US-Dollar
+0,235
+2,80 %
+2,80 %
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mo | Profound Medical Corp (2): Profound enters deal with Siemens re: prostate therapy | 8 | Stockwatch | ||
| Mo | Profound Medical, Siemens Healthineers team up on MRI-guided prostate therapy | 4 | MassDevice | ||
| Mo | Profound Medical Corp.: Profound Medical and Siemens Healthineers to Offer a Complete Solution for MRI-guided Prostate Therapy | 10 | GlobeNewswire (USA) | ||
| 26.11. | Profound Medical Corp.: Profound Medical to Unveil Next TULSA-AI Module, 'UA Alignment Assistant' | 2 | GlobeNewswire (USA) | ||
| 26.11. | Profound Medical Corp. - 6-K, Report of foreign issuer | - | SEC Filings | ||
| 08.11. | Profound Medical reports Q3 results | 4 | Seeking Alpha | ||
| PROFOUND MEDICAL Aktie jetzt für 0€ handeln | |||||
| 04.11. | Profound Medical Corp (2): Profound Medical receives Category 1 CPT code for Tulsa | 1 | Stockwatch | ||
| 04.11. | Profound Medical Corp.: Profound Medical Announces TULSA Reimbursement Raised to Urology APC Level 7 Under CMS Outpatient Prospective Payment System (OPPS) Final Rule for CY2025 | 108 | GlobeNewswire (Europe) | - TULSA to stand above all other covered prostate disease treatment modalities at Urology Level 7 reimbursement - - First-time CPT® code reimbursement for TULSA to be effective January 1,... ► Artikel lesen | |
| 04.11. | Profound Medical Corp. - 6-K, Report of foreign issuer | - | SEC Filings | ||
| 18.10. | Profound Medical Corp (2): Profound Medical to release Q3 2024 results Nov. 7 | 1 | Stockwatch | ||
| 17.10. | Profound Medical Corp (2): Profound Medical appoints Tamberrino as CCO | 3 | Stockwatch | ||
| 16.10. | Profound Medical Corp. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 16.10. | Profound Medical Corp.: Profound Medical Appoints Tom Tamberrino as Chief Commercial Officer | 366 | GlobeNewswire (Europe) | - Mr. Tamberrino and Profound's CEO, Arun Menawat, previously worked together at NOVADAQ before it was acquired by Stryker in 2017 - - Appointment comes as Profound continues to make final preparations... ► Artikel lesen | |
| 16.09. | Profound Medical Corp. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 12.09. | Profound Medical Corp. - S-8, Securities to be offered to employees in employee benefit plans | 1 | SEC Filings | ||
| 04.09. | Profound Medical Corp. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 04.09. | Profound Medical Corp.: Profound Medical to Participate in Lake Street's Best Ideas Growth Conference | 1 | GlobeNewswire (USA) | ||
| 09.08. | Earnings call: Profound Medical Q2 2024 results show strong growth | 1 | Investing.com | ||
| 08.08. | Profound Medical Corp. - 6-K, Report of foreign issuer | - | SEC Filings | ||
| 18.07. | Profound Medical Corp (2): Profound Medical to release Q2 results Aug. 8 | 2 | Stockwatch |
Seite:
1 2 Weiter >>
33 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| EMEIS | 5,483 | -1,33 % | emeis: Upturn in Performance Confirmed in Third-Quarter 2024 | Revenue up +8.3%, occupancy rate up +2.6 points
Regulatory News:
emeis (Paris:EMEIS):
Growth in all core activities and in all geographical areas (revenue and occupancy rate)
Solid... ► Artikel lesen | |
| NANO-X IMAGING | 6,110 | -6,22 % | Nano-X Imaging Ltd. (NNOX): A Bear Case Theory | ||
| BUTTERFLY NETWORK | 3,310 | -1,78 % | Butterfly Network Reports Third Quarter 2024 Financial Results | BURLINGTON, Mass. & NEW YORK--(BUSINESS WIRE)--Butterfly Network, Inc. (NYSE: BFLY) ("Butterfly" or the "Company"), a digital health company transforming care with portable, semiconductor-based... ► Artikel lesen | |
| GOODRX | 4,835 | -2,52 % | Pennsylvania pharmacies seek to centralize GoodRx antitrust claims in Rhode Island | ||
| TALKSPACE | 3,445 | -0,72 % | Espresa Partners with Talkspace to Boost Employee Well-Being with Accessible Mental Health Benefits | Espresa has partnered with Talkspace to expand mental health support for employees. Through Espresa's platform, clients now have access to Talkspace's 5,000+ licensed therapists, offering secure, on-demand... ► Artikel lesen | |
| CARMAT | 1,098 | -4,69 % | Successful first "Aeson European User Meeting", marking an important step in the deployment of CARMAT's artificial heart | More than 100 healthcare professionals from 41 hospitals and 10 countries rallied to share their experiences of the Aeson® artificial heart All hospitals taking part in the event confirmed... ► Artikel lesen | |
| JOINT CORP | 11,560 | -1,37 % | The Joint Corp. to Participate in the 13th Annual ROTH Deer Valley Event | ||
| MIMEDX | 9,470 | +0,96 % | MiMedx Group Stock Soars to 52-Week High of $9.62 | ||
| HYPERFINE | 1,000 | 0,00 % | Hyperfine, Inc. Reports Third Quarter 2024 Financial Results | GUILFORD, Connecticut, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared portable... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 94,97 | -1,12 % | 5 Analysts Assess PROCEPT BioRobotics: What You Need To Know | ||
| PROGYNY | 15,260 | -2,12 % | Here's What Led to a Sharp Drop in Progyny's (PGNY) Share Price | ||
| BIOMERICA | 0,370 | -10,15 % | Biomerica, Inc.: Nasdaq grants Biomerica an additional 180 days to meet listing compliance requirements | IRVINE, Calif., Nov. 07, 2024 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA), a leading global provider of advanced medical diagnostics, announced that it has been granted an additional 180-day... ► Artikel lesen | |
| ATRICURE | 36,080 | -2,67 % | Pre-market Movers: ASP Isotopes, NerdWallet, Reddit, AtriCure, Qorvo | OLATHE (dpa-AFX) - The following are some of the stocks making big moves in Wednesday's pre-market trading (as of 08.05 A.M. ET).In the Green ASP Isotopes Inc. (ASPI) is up over 44% at $8.33.
NerdWallet... ► Artikel lesen | |
| LIFEMD | 6,200 | -5,63 % | LifeMD, Inc.: LifeMD Reports Third Quarter 2024 Results | Total revenues increased 38% year-over-year to $53.4 million with telehealth revenue up 65%Record gross margin of 90.6%, up 300 basis points from the year-ago periodAdjusted EBITDA increased 33% to... ► Artikel lesen | |
| PROPHASE LABS | 0,715 | 0,00 % | ProPhase Labs, Inc.: ProPhase Labs Announces Positive Updates on Strategic Initiatives Company Anticipates Multiple Liquidity Events in H1 2025 | Projections for Pharmaloz Manufacturing: Approximately $16-17 Million in Revenue, $6-7 Million in Pre-Tax Earnings for 2025 Strategic Partnership Discussions Begin for BE-Smart Esophageal Cancer... ► Artikel lesen |
Das Unternehmen PROFOUND MEDICAL CORP kann der Branche Gesundheitswesen zugeordnet werden. Die relative Kursveränderung beträgt aktuell +2,80 % bei einem Aktienkurs von 8,630 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu PROFOUND MEDICAL CORP finden Sie auf Wallstreet Online.
